Airsonett signs agreement with Russian partner

Airsonett AB has recently signed an exclusivity agreement with the Russian corporation Cryotec LLC. Cryotec will act as a distributor for Airsonett in Russia. The agreement covers Airsonett's product Protexo® which is a non-pharmaceutical assistive device for the treatment of moderate to severe perennial allergic asthma.

The distribution agreement is initially two years with a possibility for another three year if certain criteria are met.

"This agreement will speed up Airsonett's expansion in the interesting East-European region" states Peter Ekolind, Marketing and Sales Director at Airsonett AB. " We are very pleased to have Cryotec as partners since they have a deep knowledge of the local market conditions and have well established contacts with the Russian medical professionals and other key groups we want to reach."

Airsonett is a research based medical technology company with a unique technology which leads the development of preventative and secondary preventative treatment of allergic asthma as well as management of airborne bacteria and virus contamination.

For more information, please contact:
Peter Ekolind, Global Marketing and Sales Director, Airsonett AB, tel. +46 70 341 55 60, e-mail peter.ekolind@airsonett.com